• Immunogenicity Assessment

    • Therapeutic In Silico Services
      • ISPRI™ Website
      • ISPRI Downselect™
      • ISPRI Quantify™
      • ISPRI Analyze™
      • ISPRI Evaluate™
      • ISPRI-HCP™
      • ISPRI Design™
      • PANDA® Screening
    • Vaccine In Silico Services
      • iVAX™
      • EpiCC™
      • Ancer®
      • PreVAX™
    • Lab Services
      • HLA Binding Assay
      • Naive CD4+ T Cell Assay
      • Innate Assay
    • Consulting Services
  • About Us
    • Leadership
    • Careers
  • Partner
  • Press
    • News
    • Events
    • Publications
  • Contact Us
Computational vaccinology and the ICoVax 2012 workshop

Computational vaccinology and the ICoVax 2012 workshop

by Adam | Oct 22, 2016

BMC Bioinformatics. 2013;14 Suppl 4:I1.doi: 10.1186/1471-2105-14-S4-I1. Epub 2013 Mar 8. PubMed PMID: 23514034; PubMed Central PMCID: PMC3599086.
Integrated assessment of predicted MHC binding and cross-conservation with self reveals patterns of viral camouflage

Integrated assessment of predicted MHC binding and cross-conservation with self reveals patterns of viral camouflage

by Adam | Oct 22, 2016

BMC Bioinformatics 2014, 15 (Suppl 4): S1 doi:10.1186/1471-2105-15-S4-S1.
Development and validation of an epitope prediction tool for swine (PigMatrix) using the pocket profile method

Development and validation of an epitope prediction tool for swine (PigMatrix) using the pocket profile method

by Adam | Oct 22, 2016

BMC Bioinformatics. BMC Bioinformatics. 2015 Sep 15;16(1):290. doi: 10.1186/s12859-015-0724-8.

Recent Posts

  • Thinking Out Loud: December 2024
  • EpiVax Drives Immunogenicity Innovation in 2024: Year in Review
  • Supporting Health Equity: EpiVax Highlights Partnerships and New Research from Clínica Esperanza and GAIA Vaccine Foundation
  • Artificial Intelligence / Human Intelligence Workshop 2025
  • Thinking Out Loud: November 2024

Recent Comments

No comments to show.

Join our newsletter

 Stay up to date with EpiVax and greater industry news, events, and technological advancements with this monthly update written by EpiVax co-founder and CSO, Dr. Annie De Groot. 

Explore

Therapeutic In Silico Services

Vaccine In Silico Services

Lab Services

Consulting

LinkedIn

About Us

Careers

Partner

News

Events

Publications

Contact Us

We use cookies to ensure that we give you the best experience on our website. By clicking 'accept', you consent to our use of cookies.AcceptDecline